Search Result

Results for "

Memory+enhancer

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5-HT Receptor (1) Adrenergic Receptor (1) Aminopeptidase (1) Angiotensin Receptor (1) Apoptosis (2) Bcl-2 Family (2) Cholinesterase (ChE) (2) DNA/RNA Synthesis (3) Dopamine Receptor (1) HDAC (1) Histamine Receptor (1) iGluR (3) Melanocortin Receptor (1) Monoamine Oxidase (1) nAChR (4) NF-κB (2) Phosphodiesterase (PDE) (2) Potassium Channel (1) Reactive Oxygen Species (ROS) (1) Reference Standards (2) TNF Receptor (1)
By Research Areas:	Cardiovascular Disease (4) Inflammation/Immunology (1) Neurological Disease (18)

By Targets:

5-HT Receptor (1)

Adrenergic Receptor (1)

Aminopeptidase (1)

Angiotensin Receptor (1)

Apoptosis (2)

Bcl-2 Family (2)

Cholinesterase (ChE) (2)

DNA/RNA Synthesis (3)

Dopamine Receptor (1)

HDAC (1)

Histamine Receptor (1)

iGluR (3)

Melanocortin Receptor (1)

Monoamine Oxidase (1)

nAChR (4)

NF-κB (2)

Phosphodiesterase (PDE) (2)

Potassium Channel (1)

Reactive Oxygen Species (ROS) (1)

Reference Standards (2)

TNF Receptor (1)

By Research Areas:

Cardiovascular Disease (4)

Inflammation/Immunology (1)

Neurological Disease (18)

Inhibitors & Agonists

Peptides

Natural
Products

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N0307

Ciwujianoside B	Bcl-2 Family NF-κB DNA/RNA Synthesis Apoptosis	Cardiovascular Disease Neurological Disease
Ciwujianoside B is an orally active, blood-brain barrier penetrable radioprotective agent and memory enhancer. Ciwujianoside B reduces radiation-induced DNA damage, cell cycle arrest and apoptosis, downregulates NF-κB and the Bax/Bcl-2 ratio, and enhances the proliferative capacity of bone marrow cells. Ciwujianoside B enhances object recognition memory in normal mice and induces dendritic extension in primary cultured cortical neurons. Ciwujianoside B can be used in studies related to hematopoietic system radiation injury and memory enhancement .

HY-112831

Osoresnontrine 1 Publications Verification BI-409306	Phosphodiesterase (PDE)	Neurological Disease
Osoresnontrine (BI-409306) is a potent and selective PDE9A inhibitor, with an IC₅₀ of 52 nM, and shows weak activity against other PDEs, such as PDE1A (IC₅₀, 1.4 µM), PDE1C (IC₅₀, 1.0 µM), PDE2A, PDE3A, PDE4B, PDE5A, PDE6AB, PDE7A, and PDE10A (IC₅₀ all > 10 μM); Osoresnontrine can be used in the research of memory enhancement in CNS disorders.

HY-P3585

Epobis	TNF Receptor	Neurological Disease Inflammation/Immunology
Epobis, a dendrimeric peptide, is a recombinant form of erythropoietin. Epobis is a potent erythropoietin receptor agonist. Epobis promotes neuritogenesis in primary motoneurons. Epobis decrease TNF release and crosses the blood-brain barrier. Epobis has anti-inflammatory and memory enhancing properties .

HY-10063

Ispronicline TC-1734; ACD3480	nAChR	Neurological Disease
Ispronicline (TC-1734), an orally active, brain-selective α4β2 nicotine acetylcholine receptor (nAChR) partial agonist, has shown memory-enhancing properties in rodents and a good tolerability profile. Ispronicline binds to the α4β2 nAChR with high affinity (K_i=11 nM) and is highly selective to other nAChRs such as α7 nAChR and α3β4 nAChR .

HY-101363

1-BCP Piperonylic acid piperidide	iGluR	Neurological Disease
1-BCP (Piperonylic acid piperidide) is a centrally active agent that modulates AMPA receptor gated currents. 1-BCP is a memory-enhancing agent .

HY-118642

D-Ribose-L-cysteine	Cholinesterase (ChE) Reactive Oxygen Species (ROS)	Cardiovascular Disease Neurological Disease
D-Ribose-L-cysteine is an orally active cysteine analog. D-Ribose-L-cysteine improves cellular antioxidant capacity by enhancing intracellular glutathione (GSH) biosynthesis. In addition, D-Ribose-L-cysteine has a memory-enhancing effect and can reverse Scopolamine (HY-N0296)-induced memory impairment by inhibiting oxidative stress and acetylcholinesterase (AChE) activity. D-Ribose-L-cysteine can be used in the study of neurodegenerative and cardiovascular diseases .

HY-19146

CL-275838	Others	Neurological Disease
CL-275838 is a memory-enhancing agent, also with potent antidepressant activities.

HY-N9737

(−)-Acutumine	Others	Neurological Disease
(−)-Acutumine is a tetracyclic chloroalkaloid that exhibits selective cytotoxicity to cultured human T cells and memory-enhancing properties in the Wistar rat model .

HY-120710

DNS-8254	Phosphodiesterase (PDE)	Neurological Disease
DNS-8254 is an oral active and brain-penetrating PDE2a inhibitor with the IC₅₀ of 8 nM. DNS-8254 shows memory enhancing effects in a rat model .

HY-139122

Butyrylhydroxamic acid N-Hydroxybutanamide	HDAC	Cardiovascular Disease Neurological Disease
Butyrylhydroxamic acid (N-Hydroxybutanamide) is a potent inhibitor of histone deacetylase (HDAC). Butyrylhydroxamic acid enhances memory in behavioral models of rodents and can be used as memory enhancers, mood stabilizers, and β-chain hemoglobin disease studies .

HY-19648B

Ebiratide TFA HOE-427 TFA	nAChR	Neurological Disease
Ebiratide (HOE-427) TFA is an ACTH 4-9 derivative, which acts directly on the central nervous system and exhibits memory-enhancing efficacy. Ebiratide TFA enhances acetycholine (ACh) metabolism in rat brain .

HY-19648

Ebiratide HOE-427 free base	Melanocortin Receptor nAChR	Neurological Disease
Ebiratide (HOE-427 free base) is an ACTH 4-9 derivative, which acts directly on the central nervous system and exhibits memory-enhancing efficacy. Ebiratide enhances acetycholine (ACh) metabolism in rat brain .

HY-N0307R

Ciwujianoside B (Standard)	Reference Standards Bcl-2 Family NF-κB DNA/RNA Synthesis Apoptosis	Cardiovascular Disease Neurological Disease
Ciwujianoside B (Standard) is the analytical standard of Ciwujianoside B. This product is intended for research and analytical applications. Ciwujianoside B is an orally active, blood-brain barrier penetrable radioprotective agent and memory enhancer. Ciwujianoside B reduces radiation-induced DNA damage, cell cycle arrest and apoptosis, downregulates NF-κB and the Bax/Bcl-2 ratio, and enhances the proliferative capacity of bone marrow cells. Ciwujianoside B enhances object recognition memory in normal mice and induces dendritic extension in primary cultured cortical neurons. Ciwujianoside B can be used in studies related to hematopoietic system radiation injury and memory enhancement.

HY-101363R

1-BCP (Standard) Piperonylic acid piperidide (Standard)	Reference Standards iGluR	Neurological Disease
1-BCP (Standard) is the analytical standard of 1-BCP. This product is intended for research and analytical applications. 1-BCP (Piperonylic acid piperidide) is a centrally active agent that modulates AMPA receptor gated currents. 1-BCP is a memory-enhancing agent .

HY-19225A

Ensaculin free base KA-672; Anseculin	iGluR 5-HT Receptor Adrenergic Receptor Dopamine Receptor	Neurological Disease
Ensaculin free base (KA-672) is a NMDA antagonist and have high affinities to serotonergic 5-HT_1A and 5-HT₇ receptors, adrenergic α₁, and dopaminergic D₂ and D₃ receptors. Ensaculin free base is a memory-enhancing agent. Ensaculin free base has the potential as an antidementia agent acting on various transmitter systems .

HY-146383

H3R antagonist 2	Histamine Receptor Cholinesterase (ChE) Monoamine Oxidase	Neurological Disease
H3R antagonist 2 (Compound 23) is a multitarget histamine H₃ receptor (H₃R) antagonist with a K_i of 170 nM for hH₃R . H3R antagonist 2 shows inhibitory effects with IC₅₀ values of 180, 880 and 775 nM for acetylcholinesterase, butyrylcholinesterase and human monoamine oxidase B (hMAO B), respectively. H3R antagonist 2 shows favorable anti-neuropathic pain and memory-enhancing effects. H3R can across BBB .

HY-18176

SEN 78702	nAChR Potassium Channel	Neurological Disease
SEN 78702 is an orally active, selective, full α7 nAChR agonist, with a pEC₅₀ of 6.13. SEN 78702 has an acceptable hERG inhibition (IC₅₀: 15.8 μM). SEN 78702 induces memory enhancement .

HY-P11643

LVV-hemorphin-7	Angiotensin Receptor Aminopeptidase DNA/RNA Synthesis	Neurological Disease
LVV-hemorphin-7 is an Angiotensin IV receptor ligand and IRAP inhibitor (IC₅₀s: 17.6 nM for sheep adrenal IRAP; 5.0 nM for sheep cerebellum IRAP). LVV-hemorphin-7 inhibits the catalytic activity of IRAP. LVV-hemorphin-7 stimulates DNA synthesis. LVV-hemorphin-7 elicits a number of physiological effects, including cellular proliferation and memory enhancement .

Cat. No.	Product Name	Target	Research Area